Solid Organ Transplant Benefits to Change for Texas Medicaid

Similar documents
Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

APPENDIX A Certification of Advanced Disease:

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

Cardiac Rehabilitation Services

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Folotyn (pralatrexate)

Related Policies None

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC)

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

Annex III. Amendments to relevant sections of the Product Information

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.

Donating a Kidney for Transplantation. Living Kidney Donation Patient Education

Indications and Limitations of Coverage and/or Medical back to top

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

HIP REPLACEMENT SURGERY (ARTHROPLASTY)

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

Obesity/Morbid Obesity/BMI

US Public Health Service Clinical Practice Guidelines for PrEP

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

Methadone Maintenance Treatment for Opioid Dependence

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Commissioning Policy: South Warwickshire CCG (SWCCG)

CLINICAL MEDICAL POLICY

Benefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016

Physical, Occupational, and Speech Therapy - Children (Acute and Chronic)

Dear Student, IMMUNIZATION RECORD INSTRUCTIONS

Immunisation and Disease Prevention Policy

Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid

SCALES NW HEARING PROTECTION PROGRAM

Center for Circulatory Support. The Center for Circulatory Support strives for continuous improvement in quality and patient outcomes

Limitations and Exclusions (What is Not Covered)

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

Referral Criteria: Inflammation of the Spine Feb

A Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Administrstrative Procedure

2017 CMS Web Interface

Opioid Analgesics PA Request Provider Checklist

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

Request for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax

ICD-10-CM Coding Basics Chapter Specifics

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

OTHER AND UNSPECIFIED DISORDERS

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

o Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17

Colorado Essential Health Benefit for Children

Rate Lock Policy. Contents

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

FDA Dietary Supplement cgmp

Diabetes: HbA1c Poor Control (NQF 0059)

Hospital Preparedness Checklist

2018 CMS Web Interface

Medical Student Immunization Requirements

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

Instructions and Helpful Information for D-5 Form. Preliminary Approval of Dissertation and Request for Oral Defense (D-5)

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

Drug Therapy Guidelines

Diabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)

Summary of Significant Changes. Policy

Erythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals

2017 CMS Web Interface

Appendix C SCHEDULE OF BENEFITS FOR THE LOW COST MEDICAL PLAN OF BENEFITS

Meeting the Nutritional Requirements of Individuals with Dementia

2017 CMS Web Interface

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

2018 CMS Web Interface

HEDIS. Healthcare Effectiveness Data & Information Set (HEDIS ) QUALITY MANAGEMENT PROGRAM SECTION 8

Ancillary Symposia Request for Proposals Partner with the Endocrine Society to Educatte the Endocrine Community.

Meeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C

Pharmacy Prior Authorization Growth Hormone- Clinical Guidelines. Serostim Zorbtive somatropin

Yescarta (axicabtagene ciloleucel) (Intravenous)

Hearing Service Fees and Fee Codes Effective: January 01, 2019

LTCH QUALITY REPORTING PROGRAM

Drug Therapy Guidelines

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

2017 Optum, Inc. All rights reserved BH1124_112017

Appendix C. Master of Public Health. Practicum Guidelines

Lower Extremity Amputation (LEA) Considerations / Issues

Drug Therapy Guidelines

OFFICE POLICY AGREEMENT

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

Influenza (Flu) Fact Sheet

2016 CWA Political Action Fund Administrative Procedures Checklist

High Performance Network Quality Criteria for Designation

Technical Specifications of Pediatric Ambulatory Care Sensitive Condition Hospitalizations

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CANCER CLINICAL TRIAL

QP Energy Services LLC Hearing Conservation Program HSE Manual Section 7 Effective Date: 5/30/15 Revision #:

Transcription:

Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a rate hearing and apprval f expenditures. Prviders will be ntified when the rates and expenditures are apprved. Nte: This article applies t claims submitted t TMHP fr prcessing. Fr claims prcessed by a Medicaid managed care rganizatin (MCO), prviders must refer t the MCO fr infrmatin abut benefits, limitatins, prir authrizatin, and reimbursement. Effective fr dates f services n r after April 1, 2015, slid rgan transplant benefits will change fr Texas Medicaid. Slid rgan transplants are a benefit f Texas Medicaid when medically necessary based n safety and efficacy, as demnstrated by scientific evidence and by cntrlled clinical studies, in accrdance with the Texas Administrative Cde (TAC). Cvered slid rgan transplants include: Heart Intestinal Kidney Liver Lung Pancreas r simultaneus kidney- pancreas Slid rgan transplants are limited t clients with a critical medical cnditin wh are expected t have a successful clinical utcme that will result in a return t imprved functinal independence. Expenses incurred fr prcurement f a living dnr s rgan are nt a benefit f Texas Medicaid. All slid rgan transplants must be perfrmed in a Medicaid enrlled facility that is certified by United Netwrk f Organ Sharing (UNOS) r designated as a Children s Hspital with a transplant unit r prgram. The facility must be in Texas, unless there are n Texas facilities certified by UNOS r designated as a Children s Hspital with a transplant unit r prgram fr the requested prcedure. All requests fr ut-f-state (OOS) services, whether fr pre-transplant evaluatin, transprtatin, r pst-transplant mnitring, must be sent t the medical directr fr prir authrizatin review. Texas Medicaid will cnsider authrizing OOS services when the fllwing criteria are met: The client des nt leave Texas t receive care that can be received in Texas. An in-state facility apprved fr the prcedure has declined t accept the client and dcumentatin is submitted t explain why the in-state team cannt perfrm the prcedure.

There is n physician prvider r facility with the level f expertise required t perfrm the necessary prcedure available in Texas, r the client has received an initial transplant at the OOS facility and requires additinal transplant services due t cmplicatins r graft lss. There is reasnable assurance that the client meets the clinical criteria required by Texas Medicaid fr transplant apprval. The service is necessary, reasnable, and federally allwable, and the facility and physicians agree t accept Medicaid reimbursement fr these services. Additinally, the OOS facility must be certified by UNOS r designated as a Children s Hspital with a transplant unit r prgram. When requesting an OOS prir authrizatin fr a pre-transplant evaluatin, the prvider must submit a cpy f the transplant evaluatin perfrmed by a Texas facility t supprt the need fr an OOS slid rgan pre-transplant evaluatin. When requesting an OOS prir authrizatin fr transplant f a slid rgan, the prvider must submit a cpy f the transplant evaluatin perfrmed by a Texas facility and a cpy f the transplant evaluatin perfrmed by the OOS facility t supprt the need fr an OOS slid rgan transplant. When requesting an OOS prir authrizatin fr pst-transplant mnitring r ther psttransplant services, the prvider must submit dcumentatin that the client received the initial transplant at the same OOS facility t include cmplicatins r graft lss if present, in rder t supprt the need fr OOS slid rgan pst-transplant mnitring r ther pst-transplant services. General Prir Authrizatin Requirements Slid rgan transplant prir authrizatin requests must include all f the fllwing: A cmplete histry and physical A statement f the current medical cnditins and status f the transplant recipient Dcumentatin f hw the client meets the prir authrizatin criteria specified fr the transplant requested Dcumentatin f the absence f c-mrbidities r cntraindicatins such as the fllwing: Severe pulmnary hypertensin End-stage cardiac, renal, hepatic, r ther rgan dysfunctin unrelated t the primary disrder Uncntrlled HIV infectin r AIDS defining illness Multiple rgan cmprmise secndary t infectin, malignancy, r cnditin with n knwn cure Onging r recurrent active infectins that are nt effectively treated Psychiatric instability severe enugh t jepardize incentive fr adherence t medical regimen

Active alchl r chemical dependency that might interfere with cmpliance t a medical regimen Histry f cmpliance with ther medical treatments, regimen, and plan f care Nte: Backbench prcedures d nt require prir authrizatin but may nly be reimbursed when a crrespnding transplant prcedure has been paid fr the same date f service. Additinal prir authrizatin changes, if applicable, specific t each type f transplant are utlined in the fllwing sectins. Nte: Clients wh are birth thrugh 20 years f age and wh d nt meet the criteria fr cverage may be cnsidered thrugh the Cmprehensive Care Prgram (CCP). Heart Transplants Assistant surgery prcedure cde 33945 will be a benefit fr nurse practitiners (NPs), clinical nurse specialists (CNSs), and physician assistants (PAs). Backbench prcedure cde 33944 will be a benefit when perfrmed in the inpatient hspital setting by a physician. Assistant surgery prcedure cde 33944 will als be payable t NPs, CNSs, and PAs. Prcedure cde 33944 may nly be reimbursed when prcedure cde 33945 has been paid fr the same date f service. Prir Authrizatin Criteria Prcedure cde 33945 may be cnsidered fr prir authrizatin with medical necessity dcumentatin that indicates a New Yrk Heart Assciatin (NYHA) Class III r IV cardiac disease with ne f the fllwing medical cnditins: Cngenital heart disease Valvular heart disease Viral cardimypathy Familial r restrictive cardimypathy Intestinal Transplants An intestinal transplant may be cnsidered fr clients wh are dependent n parental nutritin and have cmprmised venus access, have had tw r mre episdes f central line sepsis, r wh have begun t manifest prgressive parental nutritin assciated liver dysfunctin. Small bwel transplantatin may be cnsidered fr clients with irreversible intestinal failure including, but nt limited t: Shrt bwel syndrme Pseud-bstructin Micrvillus inclusin Tumr Assistant surgery prcedure cdes 44135 and 44136 will be a benefit when perfrmed in the inpatient hspital setting by a physician, NP, CNS, r PA.

Assistant surgery prcedure cdes 44715, 44720, and 44721 will be a benefit fr NPs, CNSs, and PAs. Prcedure cdes 44715, 44720, and 44721 may nly be reimbursed when prcedure cde 44135 has been paid fr the same date f service. Kidney Transplants Backbench prcedure cdes 50323, 50325, 50327, 50328, and 50329 may nly be reimbursed when prcedure cde 50360, 50365, r S2065 has been paid fr the same date f service. Prir Authrizatin Criteria Prcedure cdes 50360 and 50365 may be cnsidered fr prir authrizatin with medical necessity dcumentatin f ne f the fllwing: Hemdialysis r cntinuus ambulatry peritneal dialysis Chrnic renal failure with anticipated deteriratin t end-stage renal disease End-stage renal disease, evidenced by a creatinine clearance belw 20 ml/min r develpment f symptms f uremia End-stage renal disease that requires dialysis r is expected t require dialysis within the next 12- t 18-mnth perid Liver Transplants Transplant prcedure cde 47133 will be a benefit when prir authrized and perfrmed in the inpatient hspital setting by a physician. Backbench prcedure cdes 47143, 47144, 47145, 47146, and 47147 will be a benefit when perfrmed in the inpatient hspital setting by a physician. Assistant surgeries perfrmed fr the fllwing prcedure cdes will als be payable t NPs, CNSs, and PAs: Prcedure Cdes 47133 47135 47136 47143 47144 47145 47146 47147 Backbench prcedure cdes 47143, 47144, 47145, 47146, and 47147 may be reimbursed nly when prcedure cde 47135 r 47136 has been paid fr the same date f service. Lung Transplants Transplant prcedure cde S2060 will be a benefit when prir authrized and perfrmed in the inpatient hspital setting by a physician. Backbench prcedure cdes 32855 and 32856 will be a benefit when perfrmed in the inpatient hspital setting by a physician. Assistant surgery prcedure cdes 32851, 32852, 32853, 32854, 32855, 32856, and S2060 will als be payable t NPs, CNSs, and PAs. Backbench prcedure cdes 32855 and 32856 may be reimbursed nly when prcedure cde S2060 has been paid fr the same date f service. Pancreas Transplants

Backbench prcedure cdes 48551 and 48552 will be a benefit when perfrmed in the inpatient hspital setting by a physician. Assistant surgery prcedure cdes 48551 and 48552 will als be payable t NPs, CNSs, and PAs. Prcedure cdes 48551 and 48552 may nly be reimbursed when prcedure cde 48554 r S2065 has been paid fr the same date f service. Prcedure cde 48160 will n lnger be a benefit in the utpatient hspital setting. Prir Authrizatin Criteria Prcedure cdes 48160 and 48554 may be cnsidered fr prir authrizatin with medical necessity dcumentatin that includes the fllwing: Recurrent, acute, and severe metablic and ptentially life-threatening cmplicatins requiring medical attentins such as: Hypglycemia Hyperglycemia Ketacidsis Failure f exgenus insulin-based management t achieve sufficient glycemic cntrl (HbA1c f greater than 8.0) despite aggressive cnventinal therapy Insensibility t hypglycemia; OR Satisfactry kidney functin (creatinine clearance greater than 40mL/min), except fr kidney-pancreas transplants; and Type 1 diabetes with secndary diabetic cmplicatins that are prgressive despite the best medical management; and At least tw f the fllwing secndary cmplicatins: Diabetic neurpathy Retinpathy Gastrparesis Autnmic neurpathy Extremely labile (brittle) insulin-dependent diabetes mellitus Multi-Organ Transplants Prcedure cde S2053 will n lnger be age restricted. Prcedure cdes 33933, S2054, and S2065 will be a benefit when perfrmed in the inpatient hspital setting by a physician. Assistant surgery prcedure cdes 33933, 33935, S2054, and S2065 will als be payable t NPs, CNSs, and PAs. Backbench prcedure cde 33933 may be reimbursed nly when prcedure cde 33935 has been paid fr the same date f service. Prir Authrizatin Criteria Prcedure cdes 33935, S2053, and S2054 may be cnsidered fr prir authrizatin if medical necessity dcumentatin meets the requirements fr each rgan.

Prcedure cde S2065 may be cnsidered fr prir authrizatin if medical necessity dcumentatin indicates the client meets criteria fr a pancreas transplant and has endstage renal disease that requires dialysis r is expected t require dialysis within the next 12 mnths. Fr mre infrmatin, call the TMHP Cntact Center at 1-800-925-9126.